Cutaneous Mycobacterium thermoresistibile infection in a heart transplant recipient.
A cutaneous infection by Mycobacterium thermoresistibile occurred 3 months after cardiac transplantation near the surgical scar in a diabetic patient. The organism's growth and biochemical characteristics are described, along with extensive susceptibility data. Only two previous human infections with this organism have been reported, both pulmonary. Response to oral rifampin, ethambutol, and isoniazid was complete but slow, although the organism was isoniazid-resistant.
Neeley
S P
SP
Department of Medicine, Stanford University Hospital, California.
Denning
D W
DW
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D004977:Ethambutol / Q000627:therapeutic use; D016027:Heart Transplantation; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification*; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000209:etiology*; D012293:Rifampin / Q000627:therapeutic use; D012874:Skin Diseases, Infectious / Q000188:drug therapy / Q000209:etiology*; D014184:Transplantation, Homologous / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin